About Conference

Mayo Clinic's 10th Symposium on Immune-Oncology and Tumor Microenvironment Crosstalk brings together scientists, clinical experts, and industry partners in the field of tumor microenvironment, immune therapy, anti-angiogenesis, and targeted therapy. This symposium will facilitate the exchange of ideas and new scientific direction involving basic biology and pathways that eventually lead to new individualized therapy for patients.

Highlights

Clinician scientists will present the results of ongoing clinical trials on targeted therapy including immune therapy, anti-angiogenic therapy and others. Novel genetic and imaging methods to assess the alteration of the tumor microenvironment for monitoring the effectiveness of therapeutic responses in both pre-clinical and clinical trials will be discussed. Different clinical challenges and benefits of new therapeutic avenues including cardio-oncology will be presented.